Flowchart for data selection and filtering and to illustrate characteristics of PCPs and patients.

<p>Flowchart for data selection and filtering and to illustrate characteristics of PCPs and patients.</p

Diagnostic labelling.

<p>Proportion of a specific RTI diagnosis on the sum all RTI diagnoses per practice. Mean values over all practices are shown in column 2. Mean values separately for high prescribers and low prescribers are shown column 3 and 4 respectively. Results of inferential statistical analyses can be seen in column 5.</p

Number and proportion of the three most frequent off-label indications for drugs with at least 5,000 prescriptions (year 2008, multiple counting of off-label indications per prescription).

<p>SABA: Short-acting beta-2-agonist, CGA: Cromoglicic acid, LABA: Long-acting beta-2-agonist, ICS: Inhaled corticosteroid, SAMA: Short-acting muscarinic antagonist, B2A: Beta-2-agonist, nec: not elsewhere classified.</p><p>*Exclusive missing indications.</p><p>Number and proportion of the three most frequent off-label indications for drugs with at least 5,000 prescriptions (year 2008, multiple counting of off-label indications per prescription).</p

Annual period prevalence rates per 10,000 children (≤18 years) between 2004 and 2008.

<p>Annual period prevalence rates per 10,000 children (≤18 years) between 2004 and 2008.</p

Proportion of patients with “1”, “2–11”, “12–23”, and “24+” LABA containing-prescriptions in 2008, for all patients with LABA-containing prescriptions (a), asthma patients with LABA-containing prescriptions (b), COPD patients with LABA-containing prescriptions (c), and asthma and COPD patients with LABA-containing prescriptions (d) (AHC: Mondriaan–AHC, NPCRD: Mondriaan–NPCRD).

<p>Proportion of patients with “1”, “2–11”, “12–23”, and “24+” LABA containing-prescriptions in 2008, for all patients with LABA-containing prescriptions (a), asthma patients with LABA-containing prescriptions (b), COPD patients with LABA-containing prescriptions (c), and asthma and COPD patients with LABA-containing prescriptions (d) (AHC: Mondriaan–AHC, NPCRD: Mondriaan–NPCRD).</p

Comparison of annual period prevalence rate (PPR) of LABA-containing prescriptions in 7 European databases stratified by age and sex for the year 2008.

<p>LABA: Long-acting beta-2-agonist.</p><p>CI: Confidence interval.</p><p>*Age group: 0–19 years</p><p>Comparison of annual period prevalence rate (PPR) of LABA-containing prescriptions in 7 European databases stratified by age and sex for the year 2008.</p

Main characteristics of databases.

<p>Main characteristics of databases.</p